, the Management of Adults with Hospital-acquired, Ventilatorassociated, and Healthcare-associated Pneumonia, Am J Respir Crit Care Med. 15 févr, vol.171, issue.4, pp.388-416, 2005.

J. Trouillet, Pneumonies acquises sous ventilation mécanique, Infectiologie en Réanimation, pp.407-429, 2013.

N. Safdar, C. J. Crnich, and D. G. Maki, The Pathogenesis of Ventilator-Associated Pneumonia

, Its Relevance to Developing Effective Strategies for Prevention, Réseau REARaisin, vol.50, issue.6, p.69, 2005.

W. G. Johanson, Nosocomial Respiratory Infections with Gram-Negative Bacilli: The Significance of Colonization of the Respiratory Tract, Ann Intern Med, vol.1, issue.5, p.701, 1972.

M. Leone, L. Bouadma, B. Bouhemad, O. Brissaud, S. Dauger et al., Pneumonies associées aux soins de réanimation, Anesth Réanimation. sept, vol.4, issue.5, pp.421-462, 2018.

M. Bekaert, J. Timsit, S. Vansteelandt, P. Depuydt, A. Vésin et al.,

, Attributable Mortality of Ventilator-Associated Pneumonia: A Reappraisal Using Causal Analysis, Am J Respir Crit Care Med, vol.15, issue.10, pp.1133-1142, 2011.

M. Nguile-makao, J. Zahar, A. Français, A. Tabah, M. Garrouste-orgeas et al.,

B. , Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multistate models, Intensive Care Med. mai, vol.36, issue.5, pp.781-790, 2010.

N. Safdar, C. Dezfulian, H. R. Collard, and S. Saint, Clinical and economic consequences of ventilator-associated pneumonia: a systematic review, Crit Care Med, vol.33, issue.10, pp.2184-93, 2005.

H. Dupont, H. Mentec, J. P. Sollet, and G. Bleichner, Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia, Intensive Care Med. févr, vol.27, issue.2, pp.355-62, 2001.

J. W. Kim, J. Chung, S. Choi, H. J. Jang, S. Hong et al., Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial, Bonnet R. ßlactamines et entérobactéries. In: Antibiogramme. Paris: Eska, vol.16, issue.1, pp.165-88, 2012.

A. Philippon and G. Arlet, Entérobactéries et bêta-lactamines : phénotypes de résistance naturelle, Pathol Biol. 1 avr, vol.60, issue.2, pp.112-138, 2012.

I. Cattoir, Évolution des résistances bactériennes en réanimation, Infectiologie en Réanimation, pp.37-54, 2013.

C. Verdet, Organisation génétique des céphalosporinases acquises, p.31

C. Verdet, G. Arlet, A. Mérens, S. Laouira, A. Vachée et al., , vol.9, 2009.

J. J. Rahal, C. Urban, D. Horn, K. Freeman, S. Segal-maurer et al., Class Restriction of Cephalosporin Use to Control Total Cephalosporin Resistance in Nosocomial Klebsiella, JAMA, vol.280, issue.14, pp.1233-1240, 1998.

M. Nicolas-chanoine, Les entérobactéries productrices de bêta-lactamases à spectre élargi : où sont les dangers ? Réanimation, vol.21, pp.260-267, 2012.

R. Bonnet, Growing Group of Extended-Spectrum ?-Lactamases: the CTX-M Enzymes

, Antimicrob Agents Chemother. janv, vol.48, issue.1, pp.1-14, 2004.

D. M. Livermore, R. Canton, M. Gniadkowski, P. Nordmann, G. M. Rossolini et al.,

. Ctx-m, changing the face of ESBLs in Europe, J Antimicrob Chemother. 1 févr, vol.59, issue.2, pp.165-74, 2007.

R. Ben-ami, J. Rodríguez-baño, H. Arslan, J. Pitout, C. Quentin et al., A Multinational Survey of Risk Factors for Infection with Extended-Spectrum ?-LactamaseProducing Enterobacteriaceae in Nonhospitalized Patients, Clin Infect Dis. sept, vol.49, issue.5, pp.682-90, 2009.

G. A. Jacoby and L. S. Munoz-price, The New ?-Lactamases, N Engl J Med. 27 janv, vol.352, issue.4, pp.380-91, 2005.

, Surveillance des bactéries multirésistantes dans les établissements de santé en France, p.106

A. Scanvic, L. Denic, S. Gaillon, P. Giry, A. Andremont et al., Duration of

, Colonization by Methicillin-Resistant Staphylococcus aureus after Hospital Discharge and Risk Factors for Prolonged Carriage, Clin Infect Dis. 15 mai, vol.32, issue.10, pp.1393-1401, 2001.

J. Lucet, Prévention de l'émergence ou de l'acquisition des résistances en réanimation, Infectiologie en Réanimation, pp.55-70, 2013.

K. Kaier, U. Frank, C. Hagist, A. Conrad, and E. Meyer, The impact of antimicrobial drug consumption and alcohol-based hand rub use on the emergence and spread of extendedspectrum -lactamase-producing strains: a time-series analysis, J Antimicrob Chemother. 15 janv, vol.63, issue.3, pp.609-623, 2009.

J. J. Rahal, C. Urban, and S. Segal-maurer, Nosocomial Antibiotic Resistance in Multiple Gram-Negative Species: Experience at One Hospital with Squeezing the Resistance Balloon at Multiple Sites, Clin Infect Dis. 15 févr, vol.34, issue.4, pp.499-503, 2002.

P. Nordmann, T. Naas, and L. Poirel, Global Spread of Carbapenemase-producing

. Enterobacteriaceae, Emerg Infect Dis, vol.17, pp.1791-1799, 2011.

C. Pefia, M. Pujol, A. Ricart-f, C. Ardanuy, J. Ayatst et al., Risk factors for faecal carriage of KZebsieZZa pneumoniae producing extended spectrum P-lactamase (ESBL-KP) in the intensive care unit

L. L. Maragakis, Recognition and prevention of multidrug-resistant Gram-negative bacteria in the intensive care unit, Crit Care Med. août, vol.38, pp.345-51, 2010.

A. Asensio, A. Oliver, P. González-diego, F. Baquero, J. C. Pérez-díaz et al., Outbreak of a Multiresistant Klebsiella pneumoniae Strain in an Intensive Care Unit: Antibiotic Use as Risk Factor for Colonization and Infection, Clin Infect Dis. janv, vol.30, issue.1, pp.55-60, 2000.

K. Hussein, H. Sprecher, T. Mashiach, O. I. Kassis, I. Finkelstein et al., Carbapenem Resistance Among Klebsiella pneumoniae Isolates Risk Factors, Molecular Characteristics, and Susceptibility Patterns, Infect Control Hosp Epidemiol. juill, vol.30, issue.07, pp.666-71, 2009.